Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 63Leukemia, Myeloid, Acute 31Leukemia 25Carcinoma, Renal Cell 23Lymphoma 21Kidney Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Neoplasm Metastasis 14Lymphoma, Mantle-Cell 13Myelodysplastic Syndromes 12Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 12Leukemia, Lymphocytic, Chronic, B-Cell 12Neuroblastoma 11Ovarian Neoplasms 10Congenital Abnormalities 10Lymphoma, B-Cell, Marginal Zone 9Breast Neoplasms 9Multiple Myeloma 8Hodgkin Disease 8Carcinoma, Non-Small-Cell Lung 8Stomach Neoplasms 7Recurrence 7Lymphoma, Large B-Cell, Diffuse 7Burkitt Lymphoma 7Lymphoma, Large-Cell, Immunoblastic 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Skin Neoplasms 5Pancreatic Neoplasms 5Myeloproliferative Disorders 5

Interventions

Oxaliplatin 3Irinotecan 3Fluorouracil 3Capecitabine 3Bevacizumab 3Leucovorin 2Colonoscopy 2Bisacodyl 2Aspirin 2lutetium Lu 177 dotatate 1guadecitabine 1copper dotatate CU-64 1camrelizumab 1apatinib 1aldesleukin 1XELOX 1Ursodeoxycholic Acid 1Trastuzumab 1Suction 1Simvastatin 1Radiotherapy 1Polyethylene Glycols 1Oviposition 1Lutetium-177 1Lutetium 1Ileostomy 1Folfox protocol 1Drainage 1Cyclophosphamide 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Intestinal Neoplasms × aldesleukin × Clear all
NCT02662348 2016-01-25

T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System

The First Affiliated Hospital with Nanjing Medical University

Phase 1 Unknown
6 enrolled
Gastrointestinal

Esophageal Neoplasms, Gallbladder Neoplasms, Intestinal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡